Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04412824Phase 1Completed
Phase 1, randomised, single-blind trial (2 arms), sponsored by Auburn University. Primary endpoints: Change in Neural Blood Flow at 45 months, Change in Cortisol at 125 months and 2 more. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04412824.